Evidence map›Paper›PMID 22547034›Full record

ReviewNatural product reports2012

The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites.

Jennifer Guerra-Bubb, Rodney Croteau, Robert M Williams

Abstract readReview
In one paragraph

Review in Natural product reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer Guerra-BubbDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, USA.
Rodney Croteau
Robert M Williams

Funding

TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCESR01CA070375 · NCI · COLORADO STATE UNIVERSITY-FORT COLLINS · PI SHERMAN, DAVID H, WILLIAMS, ROBERT MICHAEL · 1997 to 2018
$4.4M
BIOSYNTHESIS of TaxolR37CA055254 · NCI · WASHINGTON STATE UNIVERSITY · PI CROTEAU, RODNEY B · 2001 to 2010
$3.1M
BIOSYNTHESIS OF TAXOLR01CA055254 · NCI · WASHINGTON STATE UNIVERSITY · PI CROTEAU, RODNEY B · 1991 to 2000
$239k
NCI NIH HHS CA55254NCI NIH HHS CA70375NCI NIH HHS R01 CA055254NCI NIH HHS R01 CA070375NCI NIH HHS R37 CA055254
6 · The paper itself

Abstract

The biosynthesis of the anti-cancer drug taxol (paclitaxel) has required the collaborative efforts of several research groups to tackle the synthesis and labeling of putative biosynthetic intermediates, in concert with the identification, cloning and functional expression of the biosynthetic genes responsible for the construction of this complex natural product. Based on a combination of precursor labeling and incorporation experiments, and metabolite isolation from Taxus spp., a picture of the complex matrix of pathway oxygenation reactions following formation of the first committed intermediate, taxa-4(5),11(12)-diene, is beginning to emerge. An overview of the current state of knowledge on the early-stages of taxol biosynthesis is presented.

Indexed as

Antineoplastic Agents, PhytogenicBiological ProductsPaclitaxelMolecular StructureTaxusAntineoplastic Agents, PhytogenicBiological ProductsPaclitaxel

Identifiers

PMID22547034
PMCPMC3373433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.